GO:0019858 cytosine metabolic process: DNA Methylation Pathway, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0019858 cytosine metabolic process describes the chemical reactions and pathways involving cytosine, a pyrimidine base found in DNA and RNA.
Cytosine metabolism is dominated by methylation and demethylation reactions that regulate gene expression and genome stability.
Bisulfite sequencing and third-generation sequencing are key methods for mapping cytosine modifications at single-base resolution.
Dysregulated cytosine methylation is linked to cancer, imprinting disorders, and neurological disease.
CRISPR-based models (knockout, knock-in, point mutation) enable causal testing of cytosine-modifying enzymes.
Understanding cytosine metabolic process is essential for epigenetics, diagnostics, and therapeutic development.

Description

Cytosine metabolic process (GO:0019858) encompasses the chemical reactions and pathways involving cytosine, a pyrimidine derivative that is one of the five main bases in nucleic acids. Cytosine occurs widely in cytidine derivatives and is a central substrate for epigenetic modifications that regulate gene expression. The term is defined in QuickGO as the chemical reactions and pathways involving cytosine, 4-amino-2-hydroxypyrimidine, a pyrimidine derivative that is one of the five main bases found in nucleic acids. Researchers study this process because cytosine modifications, particularly 5-methylcytosine and its oxidized derivatives, are critical for development, cellular identity, and disease. The inheritance and dynamic regulation of cytosine methylation influence chromatin structure and transcription. Advances in sequencing technologies have made it possible to map cytosine modifications genome-wide, driving discoveries in epigenetics and precision medicine.

cytosine metabolic process At A Glance

GO ID GO:0019858
GO term cytosine metabolic process
Ontology biological_process
Synonym cytosine metabolism
Definition The chemical reactions and pathways involving cytosine, 4-amino-2-hydroxypyrimidine, a pyrimidine derivative that is one of the five main bases found in nucleic acids; it occurs widely in cytidine derivatives.
Major function Regulation of cytosine modifications including methylation and demethylation
Related processes DNA methylation, epigenetic regulation, pyrimidine metabolism
Key modifications 5-methylcytosine, 5-hydroxymethylcytosine, 5-formylcytosine, 5-carboxylcytosine

What Is GO:0019858?

In our own words, cytosine metabolic process (GO:0019858) refers to all biochemical reactions and pathways that synthesize, modify, or degrade cytosine and its derivatives. This includes the addition and removal of methyl groups, oxidation of methylcytosine, and incorporation of cytosine into nucleic acids. The process is fundamental to epigenetic regulation and genome stability.

Why Is cytosine metabolic process Important in Cell Biology?

Cytosine metabolic process is important because cytosine modifications are central to epigenetic regulation, influencing gene expression, development, and disease. The inheritance of cytosine methylation patterns is critical for maintaining cellular identity. Dysregulation of cytosine metabolism has been implicated in cancer, where aberrant methylation silences tumor suppressors or activates oncogenes. Additionally, cytosine modifications are dynamic and reversible, with oxidized derivatives serving as intermediates in active DNA demethylation. Understanding this process is essential for developing epigenetic therapies and diagnostic biomarkers.
Cytosine methylation is a key epigenetic mark regulating gene expression.
Aberrant cytosine methylation is a hallmark of many cancers.
Cytosine modifications are involved in X-chromosome inactivation and genomic imprinting.
5-hydroxymethylcytosine is an intermediate in DNA demethylation and is enriched in brain tissue.
Bisulfite sequencing and third-generation sequencing enable high-resolution mapping of cytosine modifications.
Methylation-specific PCR is a widely used method for detecting cytosine methylation in clinical samples.
Bisulfite pyrosequencing allows quantitative analysis of cytosine methylation at specific loci.
Cytosine metabolism is linked to R-loop formation and genome stability.
Dysregulated cytosine metabolism contributes to neurological disorders and imprinting disorders.
CRISPR-based models facilitate functional studies of cytosine-modifying enzymes.

What Happens During cytosine metabolic process?

Methylation of Cytosine
In simple terms: A methyl group is added to cytosine to make 5-methylcytosine.
The methylation of cytosine is catalyzed by DNA methyltransferases (DNMTs), which transfer a methyl group from S-adenosylmethionine to the carbon-5 position of cytosine, forming 5-methylcytosine (5mC). This modification is essential for gene silencing, X-chromosome inactivation, and genomic imprinting. The inheritance of cytosine methylation patterns during DNA replication ensures epigenetic memory.
Oxidation of 5-Methylcytosine
In simple terms: 5-methylcytosine can be oxidized stepwise to 5-hydroxymethylcytosine and further derivatives.
Ten-eleven translocation (TET) enzymes oxidize 5-methylcytosine to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC). These oxidized derivatives are intermediates in active DNA demethylation and can be recognized by DNA repair pathways. 5hmC is particularly abundant in brain tissue and is implicated in neuronal function.
Demethylation and Base Excision Repair
In simple terms: Oxidized cytosine derivatives are removed and replaced with unmodified cytosine.
Active DNA demethylation involves the recognition and excision of oxidized cytosine derivatives by thymine DNA glycosylase (TDG), followed by base excision repair (BER) to restore unmodified cytosine. This process is crucial for dynamic regulation of gene expression and cellular reprogramming.
Reading Cytosine Modifications
In simple terms: Proteins bind to modified cytosines to interpret the epigenetic code.
Methyl-CpG-binding domain (MBD) proteins and other readers recognize 5mC and its oxidized derivatives, recruiting chromatin-modifying complexes that alter transcription. The interplay between writers, readers, and erasers of cytosine modifications determines chromatin state and gene activity.
R-Loop Formation and Genome Stability
In simple terms: Unmethylated CpG islands can form R-loops that affect genome stability.
R-loop formation is a distinctive characteristic of unmethylated human CpG island promoters, and these structures can influence transcription and genome stability. Cytosine methylation status at promoters affects R-loop formation and associated DNA damage.

Key Genes Involved in GO:0019858 cytosine metabolic process

The following genes encode enzymes and proteins directly involved in cytosine metabolic process, including methylation, oxidation, and repair.
GeneMajor RoleResearch Relevance
DNMT1Maintenance DNA methyltransferasePropagation of methylation patterns during replication
DNMT3ADe novo DNA methyltransferaseEstablishment of new methylation marks during development
DNMT3BDe novo DNA methyltransferaseMethylation of repetitive elements and development
TET15mC to 5hmC oxidationActive demethylation and gene regulation
TET25mC to 5hmC oxidationFrequently mutated in hematopoietic malignancies
TET35mC to 5hmC oxidationZygotic reprogramming and development
TDGThymine DNA glycosylaseExcision of oxidized cytosine derivatives in BER
MBD1Methyl-CpG binding domain proteinReading methylation marks and transcriptional repression
MBD2Methyl-CpG binding domain proteinRecruitment of chromatin remodeling complexes
MBD4Methyl-CpG binding domain proteinDNA repair at methylated CpG sites
MeCP2Methyl-CpG binding proteinNeuronal function and Rett syndrome
UHRF1Ubiquitin-like PHD and RING finger domain 1Recruitment of DNMT1 to hemimethylated DNA
DNMT3LDNMT3-like proteinStimulation of de novo methylation
GADD45AGrowth arrest and DNA damage inducible alphaActive demethylation and stress response
APOBEC3AApolipoprotein B mRNA editing enzymeDeamination of cytosine in DNA and RNA
UNGUracil DNA glycosylaseExcision of uracil from deaminated cytosine
SMUG1Single-strand selective monofunctional uracil DNA glycosylaseRepair of oxidized cytosine derivatives

How Is cytosine metabolic process Regulated?

Cytosine metabolic process is regulated at multiple levels. DNA methyltransferase activity is controlled by transcriptional regulation, post-translational modifications, and interaction with accessory proteins such as UHRF1 and DNMT3L. TET enzyme activity is regulated by metabolites including alpha-ketoglutarate and by post-translational modifications. Additionally, chromatin context and R-loop formation influence the accessibility of cytosine residues to modifying enzymes. The balance between methylation and demethylation is critical for maintaining epigenetic homeostasis.

cytosine metabolic process and Human Disease

GeneDisease / BiologyPotential Experimental Model
DNMT3AAcute myeloid leukemiaKnockout cell model
TET2Myelodysplastic syndromesPoint mutation knock-in
MeCP2Rett syndromeKnock-in mouse model
TDGEmbryonic lethality and cancer predispositionConditional knockout
UHRF1Cancer and developmental disordersOverexpression and knockout
Cancer
Aberrant cytosine methylation is a hallmark of cancer, with promoter hypermethylation silencing tumor suppressor genes and global hypomethylation contributing to genomic instability. Mutations in TET2 and DNMT3A are frequent in hematological malignancies. Methylation-specific PCR and bisulfite sequencing are used to detect cancer-specific methylation patterns.
Neurological Disorders
Dysregulated cytosine metabolism, particularly 5hmC dynamics, is implicated in neurological disorders such as Rett syndrome, which is caused by mutations in MeCP2. 5hmC is enriched in the brain and plays a role in neuronal development and function.
Imprinting Disorders
Defects in cytosine methylation at imprinting control regions lead to imprinting disorders such as Beckwith-Wiedemann syndrome and Silver-Russell syndrome. Proper establishment and maintenance of methylation at these loci are essential for normal development.

From cytosine metabolic process-Related Genes to Experimental Models

Research QuestionSuitable Model
What is the effect of DNMT1 loss on methylation maintenance?DNMT1 knockout cell line
How does TET2 mutation affect 5hmC levels?TET2 point mutation knock-in
Can wild-type TET1 rescue demethylation defects?TET1 overexpression
What is the role of MeCP2 in neuronal function?MeCP2 knock-in with tagged version
How does TDG deficiency impact BER?TDG knockout
Does UHRF1 overexpression alter methylation patterns?UHRF1 overexpression

How to Study the cytosine metabolic process Process

MethodWhat It MeasuresTypical Application
Bisulfite sequencing5mC at single-base resolutionGenome-wide methylation profiling
Methylation-specific PCRMethylation status of specific lociClinical diagnostics
Bisulfite pyrosequencingQuantitative methylation at CpG sitesValidation of methylation patterns
Third-generation sequencingNative DNA modifications including 5mC and 5hmCLong-read epigenetics
ChIP-seqBinding of methylation readersChromatin state analysis
R-loop mappingR-loop formation at promotersGenome stability studies
5hmC enrichmentGlobal 5hmC levelsEpigenetic reprogramming studies
Bisulfite Sequencing
Bisulfite sequencing converts unmethylated cytosine to uracil while methylated cytosine remains unchanged, allowing single-base resolution mapping of 5mC. Bismark is a widely used aligner and methylation caller for bisulfite-seq data. Methylation-specific PCR is a cost-effective alternative for locus-specific analysis.
Third-Generation Sequencing
Third-generation sequencing platforms can directly detect cytosine modifications without bisulfite conversion, enabling long-read epigenetic analysis. This approach preserves native DNA and can distinguish 5mC from 5hmC.
Bisulfite Pyrosequencing
Bisulfite pyrosequencing provides quantitative methylation data at specific CpG sites and is suitable for clinical samples. It is often used to validate findings from genome-wide studies.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation followed by sequencing (ChIP-seq) can map the binding of proteins that read cytosine modifications, such as MBD proteins, providing insights into chromatin state.

How CRISPR Can Be Used to Study GO:0019858 cytosine metabolic process

Knockout

CRISPR knockout of genes involved in cytosine metabolism, such as DNMT1 or TET2, allows researchers to study loss-of-function phenotypes, including changes in methylation patterns and gene expression.

Point Mutation

Introducing specific point mutations in catalytic domains of DNMTs or TETs via CRISPR can dissect the enzymatic activity required for cytosine modification and its downstream effects.

Knock-in

Knock-in of tagged versions of cytosine-modifying enzymes enables live-cell imaging and proteomic analysis of their interactions and dynamics.

Overexpression

Overexpression of wild-type or mutant forms of cytosine metabolic enzymes can reveal gain-of-function effects on methylation and demethylation.

How EDITGENE Supports cytosine metabolic process Research

Researchers studying cytosine metabolic process-related genes often need to determine whether a candidate gene is causally involved in methylation dynamics, disease progression, or therapeutic response. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for cytosine metabolic process research.

Frequently Asked Questions About cytosine metabolic process

Cytosine metabolic process (GO:0019858) refers to the chemical reactions and pathways involving cytosine, including methylation, oxidation, and demethylation.
Key genes include DNMT1, DNMT3A, DNMT3B, TET1, TET2, TET3, TDG, MBD1, MBD2, MeCP2, and UHRF1.
Bisulfite sequencing, methylation-specific PCR, and bisulfite pyrosequencing are common methods.
TET enzymes oxidize 5-methylcytosine to 5-hydroxymethylcytosine and further derivatives, facilitating active demethylation.
Cancer, neurological disorders like Rett syndrome, and imprinting disorders are associated with dysregulated cytosine metabolism.
Yes, CRISPR knockout, knock-in, and point mutation models are widely used to study genes involved in cytosine metabolism.
5-hydroxymethylcytosine (5hmC) is an oxidized derivative of 5-methylcytosine, enriched in brain tissue and involved in demethylation.
Bisulfite treatment converts unmethylated cytosine to uracil, while methylated cytosine remains unchanged, allowing methylation mapping.
5mC is methylated cytosine, while 5hmC is an oxidized form that serves as an intermediate in active demethylation.
It regulates gene expression, genomic imprinting, X-chromosome inactivation, and genome stability.

Conclusion

Cytosine metabolic process (GO:0019858) is a fundamental biological process that governs epigenetic regulation through methylation and demethylation of cytosine. Its dysregulation is implicated in cancer, neurological disorders, and imprinting disorders. Advances in sequencing technologies and CRISPR-based models continue to unravel the complexities of cytosine metabolism, offering new avenues for diagnostics and therapeutics. EDITGENE provides essential tools to study this process and accelerate discoveries.

References

  1. 1. Krueger F et al.. 2011. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications.. Bioinformatics 27(11):1571-2 PMID: 21493656
  2. 2. Ginno PA et al.. 2012. R-loop formation is a distinctive characteristic of unmethylated human CpG island promoters.. Mol Cell 45(6):814-25 PMID: 22387027
  3. 3. Searle B et al.. 2023. Third-Generation Sequencing of Epigenetic DNA.. Angew Chem Int Ed Engl 62(14):e202215704 PMID: 36524852
  4. 4. Tillo D et al.. 2016. Inheritance of Cytosine Methylation.. J Cell Physiol 231(11):2346-52 PMID: 26910768
  5. 5. Derks S et al.. 2004. Methylation-specific PCR unraveled.. Cell Oncol 26(5-6):291-9 PMID: 15623939
  6. 6. Bassil CF et al.. 2013. Bisulfite pyrosequencing.. Methods Mol Biol 1049:95-107 PMID: 23913212
  7. 7. Mahé EA et al.. 2018. Reading cytosine modifications within chromatin.. Transcription 9(4):240-247 PMID: 29406813
  8. 8. Xu G et al.. 2014. Genomics special issue on 5-hydroxymethylation.. Genomics 104(5):313 PMID: 25449535
Contact Us
*
*
*
*
How did you hear about us: